跳至主要内容
临床试验/ACTRN12616000602426
ACTRN12616000602426尚未招募1 期

Thioguanine Suppositories For Proctitis. An Open Label Phase I Study To Evaluate the Efficacy and Safety of TG as a suppository

Mater Hospital Brisbane0 个研究点目标入组 10 人开始时间: 2016年5月10日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Patients to include in the study will be screened from:
  • a.Patients attending Gastroenterology outpatient clinics.
  • b.Pre-existing clinical databases in the department of Gastroenterology and Dr Florin’s private rooms at Mater Health Services, South Brisbane.
  • 2.All patients satisfying the criteria for severe proctitis will be screened and will need to meet the below inclusion and exclusion criteria.
  • a) Able to give informed consent
  • b) Age 18 and above
  • c) Clinical evidence of severe proctitis: Established diagnosis of severe Proctitis (isolated proctitis proven at a colonoscopy within 3 months of consenting and with Mayo endoscopic subscore greater than or equal to 2.)
  • d) patients who have failed the ‘standard’ combination of oral and rectal 5-ASA at the time of the consenting process as demonstrated by a partial Mayo Score greater than 3 while on standard treatment.

排除标准

  • Pregnant women

研究者

发起方
Mater Hospital Brisbane

相似试验